ABSTRACT
Research in multiple sclerosis (MS) has recently been focusing on the extent of neuroaxonal damage and its contribution to disease outcome. In the present study, we examined spinal cord tissue from 30 clinically well-characterized MS patients. MS, amyotrophic lateral sclerosis (ALS), and control spinal cord tissue were subjected to morphometric analysis and immunohistochemistry for markers of cell damage and regeneration. Data were related to disease duration and age at death. Here, we present evidence for substantial, nonprogressive neuronal loss on the cervical and lumbar levels early in the disease course of MS. Chromatolytic neurons and immunoreactivity for c-Jun and GAP43 were observed in the ventral gray matter in and adjacent to actively demyelinating lesions, pointing toward neuronal damage and regeneration as an early response to lesion formation.
Subject(s)
Multiple Sclerosis/pathology , Neurons/pathology , Spinal Cord/pathology , Adult , Aged , Aged, 80 and over , Amyotrophic Lateral Sclerosis/diagnosis , Amyotrophic Lateral Sclerosis/pathology , Cell Count/methods , Early Diagnosis , Female , Humans , Male , Middle Aged , Multiple Sclerosis/diagnosis , Time FactorsABSTRACT
BACKGROUND: Cervical artery dissection is a leading cause of cerebral ischemia in young adults. Morphological investigations have shown alterations in the extracellular matrix (ECM) of affected vessel walls. As matrix metalloproteinases (MMP) play a central role in the regulation of the ECM, an increased expression of these enzymes might lead to the endothelial damage in spontaneous cervical artery dissection (sCAD). Five different DNA polymorphisms in MMP-1, -3, -9 and -12 were tested for their frequency in patients with sCAD and compared with those of a control population. METHODS: Blood was sampled from 70 unrelated patients presenting consecutively in the department of neurology of the Aachen University Medical School with sCAD and from 87 control subjects living in the same area as the patients. The MMP polymorphisms were analyzed with hybridization probes using the LightCycler (Roche Diagnostics), by sequencing using the ABI 310 Genetic Analyzer (Applied Biosystems) and with the GeneScan program on a ABI 310 Genetic Analyzer. RESULTS: No statistically significant differences in the allelic distribution were found between sCAD patients and the controls. CONCLUSION: Alleles of these 5 functional polymorphisms of MMPs seem not to be associated with structural alterations in the blood vessel wall of sCAD patients. However, this does not exclude a pathogenetic role for MMPs in sCAD via secondary factors such as cytokines that are able to induce these enzymes in cervical blood vessel walls.
Subject(s)
Carotid Artery, Internal, Dissection/genetics , Matrix Metalloproteinases, Secreted/genetics , Polymorphism, Genetic , Adult , Aged , Alleles , Carotid Artery, Internal, Dissection/blood , Female , Genetic Predisposition to Disease , Humans , Male , Matrix Metalloproteinases, Secreted/blood , Middle AgedABSTRACT
BACKGROUND: A major class of axon growth-repulsive molecules associated with CNS scar tissue is the family of chondroitin sulphate proteoglycans (CSPGs). Experimental spinal cord injury (SCI) has demonstrated rapid re-expression of CSPGs at and around the lesion site. The pharmacological digestion of CSPGs in such lesion models results in substantially enhanced axonal regeneration and a significant functional recovery. The potential therapeutic relevance of interfering with CSPG expression or function following experimental injuries seems clear, however, the spatio-temporal pattern of expression of individual members of the CSPG family following human spinal cord injury is only poorly defined. In the present correlative investigation, the expression pattern of CSPG family members NG2, neurocan, versican and phosphacan was studied in the human spinal cord. METHODS: An immunohistochemical investigation in post mortem samples of control and lesioned human spinal cords was performed. All patients with traumatic SCI had been clinically diagnosed as having "complete" injuries and presented lesions of the maceration type. RESULTS: In sections from control spinal cord, NG2 immunoreactivity was restricted to stellate-shaped cells corresponding to oligodendrocyte precursor cells. The distribution patterns of phosphacan, neurocan and versican in control human spinal cord parenchyma were similar, with a fine reticular pattern being observed in white matter (but also located in gray matter for phosphacan). Neurocan staining was also associated with blood vessel walls. Furthermore, phosphacan, neurocan and versican were present in the myelin sheaths of ventral and dorsal nerve roots axons. After human SCI, NG2 and phosphacan were both detected in the evolving astroglial scar. Neurocan and versican were detected exclusively in the lesion epicentre, being associated with infiltrating Schwann cells in the myelin sheaths of invading peripheral nerve fibres from lesioned dorsal roots. CONCLUSION: NG2 and phosphacan were both present in the evolving astroglial scar and, therefore, might play an important role in the blockade of successful CNS regeneration. Neurocan and versican, however, were located at the lesion epicentre, associated with Schwann cell myelin on regenerating peripheral nerve fibres, a distribution that was unlikely to contribute to failed CNS axon regeneration. The present data points to the importance of such correlative investigations for demonstrating the clinical relevance of experimental data.
Subject(s)
Antigens/metabolism , Astrocytes/metabolism , Gliosis/metabolism , Proteoglycans/metabolism , Receptor-Like Protein Tyrosine Phosphatases, Class 5/metabolism , Spinal Cord Injuries/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Astrocytes/pathology , Cell Count , Chondroitin Sulfate Proteoglycans/metabolism , Fluorescent Antibody Technique , Gliosis/pathology , Humans , Immunohistochemistry , Lectins, C-Type/metabolism , Middle Aged , Nerve Tissue Proteins/metabolism , Neurocan , Oligodendroglia/metabolism , Spinal Cord Injuries/pathology , Time Factors , Versicans/metabolismABSTRACT
Traumatic spinal cord injury (SCI) causes severe and permanent functional deficits due to the primary mechanical insult followed by secondary tissue degeneration. The cascade of secondary degenerative events constitutes a range of therapeutic targets which, if successfully treated, could significantly ameliorate functional loss after traumatic SCI. During the early hours after injury, potent pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1beta) are synthesized and released, playing key roles in secondary tissue degeneration. In the present investigation, the ability of rolipram and thalidomide (FDA approved drugs) to reduce secondary tissue degeneration and improve motor function was assessed in an experimental model of spinal cord contusion injury. The combined acute single intraperitoneal administration of both drugs attenuated TNF-alpha and IL-1beta production and improved white matter sparing at the lesion epicenter. This was accompanied by a significant (2.6 point) improvement in the BBB locomotor score by 6 weeks. There is, at present, no widely accepted intervention strategy that is appropriate for the early treatment of human SCI. The present data suggest that clinical trials for the acute combined application of rolipram and thalidomide may be warranted. The use of such "established drugs" could facilitate the early initiation of trials.
Subject(s)
Immunosuppressive Agents/therapeutic use , Locomotion/drug effects , Phosphodiesterase Inhibitors/therapeutic use , Rolipram/therapeutic use , Spinal Cord Injuries/drug therapy , Thalidomide/therapeutic use , Animals , Disease Models, Animal , Disease Progression , Drug Therapy, Combination , Enzyme-Linked Immunosorbent Assay , Gene Expression Regulation/drug effects , Interleukin-1beta/metabolism , Male , Myelin Basic Protein/metabolism , Nerve Regeneration/drug effects , Neurofilament Proteins/metabolism , Psychomotor Performance/drug effects , Rats , Rats, Inbred Lew , Recovery of Function/drug effects , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Time Factors , Tumor Necrosis Factor-alpha/metabolismABSTRACT
BACKGROUND: Matrix metalloproteinases (MMPs) are a family of extracellular endopeptidases that degrade the extracellular matrix and other extracellular proteins. Studies in experimental animals demonstrate that MMPs play a number of roles in the detrimental as well as in the beneficial events after spinal cord injury (SCI). In the present correlative investigation, the expression pattern of several MMPs and their inhibitors has been investigated in the human spinal cord. METHODS: An immunohistochemical investigation in post mortem samples of control and lesioned human spinal cords was performed. All patients with traumatic SCI had been clinically diagnosed as having "complete" injuries and presented lesions of the maceration type. RESULTS: In the unlesioned human spinal cord, MMP and TIMP immunoreactivity was scarce. After traumatic SCI, a lesion-induced bi-phasic pattern of raised MMP-1 levels could be found with an early up-regulation in macrophages within the lesion epicentre and a later induction in peri-lesional activated astrocytes. There was an early and brief induction of MMP-2 at the lesion core in macrophages. MMP-9 and -12 expression peaked at 24 days after injury and both molecules were mostly expressed in macrophages at the lesion epicentre. Whereas MMP-9 levels rose progressively from 1 week to 3 weeks, there was an isolated peak of MMP-12 expression at 24 days. The post-traumatic distribution of the MMP inhibitors TIMP-1, -2 and -3 was limited. Only occasional TIMP immuno-positive macrophages could be detected at short survival times. The only clear induction was detected for TIMP-3 at survival times of 8 months and 1 year in peri-lesional activated astrocytes. CONCLUSION: The involvement of MMP-1, -2, -9 and -12 has been demonstrated in the post-traumatic events after human SCI. With an expression pattern corresponding largely to prior experimental studies, they were mainly expressed during the first weeks after injury and were most likely involved in the destructive inflammatory events of protein breakdown and phagocytosis carried out by infiltrating neutrophils and macrophages, as well as being involved in enhanced permeability of the blood spinal cord barrier. Similar to animal investigations, the strong induction of MMPs was not accompanied by an expression of their inhibitors, allowing these proteins to exert their effects in the lesioned spinal cord.
Subject(s)
Matrix Metalloproteinases/metabolism , Spinal Cord Injuries/metabolism , Spinal Cord/metabolism , Tissue Inhibitor of Metalloproteinases/metabolism , Adult , Aged , Aged, 80 and over , Astrocytes/metabolism , Astrocytes/pathology , Cadaver , Glial Fibrillary Acidic Protein/metabolism , Humans , Immunohistochemistry , Macrophages/metabolism , Macrophages/pathology , Microglia/pathology , Middle Aged , Spinal Cord/pathology , Spinal Cord Injuries/pathology , Time Factors , Tissue DistributionABSTRACT
Despite considerable progress in recent years, the underlying mechanisms responsible for the failure of axonal regeneration after spinal cord injury (SCI) remain only partially understood. Experimental data have demonstrated that a major impediment to the outgrowth of severed axons is the scar tissue that finally dominates the lesion site and, in severe injuries, is comprised of connective tissue and fluid-filled cysts, surrounded by a dense astroglial scar. Reactive astrocytes and infiltrating cells, such as fibroblasts, produce a dense extracellular matrix (ECM) that represents a physical and molecular barrier to axon regeneration. In the human situation, correlative data on the molecular composition of the scar tissue that forms following traumatic SCI is scarce. A detailed investigation on the expression of putative growth-inhibitory and growth-promoting molecules was therefore performed in samples of post-mortem human spinal cord, taken from patients who died following severe traumatic SCI. The lesion-induced scar could be subdivided into a Schwann cell dominated domain which contained large neuromas and a surrounding dense ECM, and a well delineated astroglial scar that isolated the Schwann cell/ECM rich territories from the intact spinal parenchyma. The axon growth-modulating molecules collagen IV, laminin and fibronectin were all present in the post-traumatic scar tissue. These molecules were almost exclusively found in the Schwann cell-rich domain which had an apparent growth-promoting effect on PNS axons. In the astrocytic domain, these molecules were restricted to blood vessel walls without a co-localization with the few regenerating CNS neurites located in this region. Taken together, these results favour the notion that it is the astroglial compartment that plays a dominant role in preventing CNS axon regeneration. The failure to demonstrate any collagen IV, laminin or fibronectin upregulation associated with the astroglial scar suggests that other molecules may play a more significant role in preventing axon regeneration following human SCI.
Subject(s)
Astrocytes/physiology , Extracellular Matrix Proteins/physiology , Nerve Regeneration/physiology , Schwann Cells/physiology , Spinal Cord Injuries/physiopathology , Adult , Aged , Aged, 80 and over , Axons/physiology , Cicatrix/physiopathology , Collagen Type IV/physiology , Extracellular Matrix/pathology , Extracellular Matrix/physiology , Fibronectins/physiology , Fluorescent Antibody Technique/methods , Glial Fibrillary Acidic Protein/physiology , Humans , Immunohistochemistry/methods , Laminin/physiology , Middle Aged , Neurofilament Proteins/physiology , Neuroglia/physiology , Receptors, Nerve Growth Factor/physiology , Spinal Cord/chemistry , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord Injuries/pathologyABSTRACT
OBJECTIVE: To correlate high-resolution magnetic resonance imaging (MRI) with immunohistopathology in the injured human spinal cord. METHODS: Postmortem MRI scans at a field strength of 9.4 T, as well as standard histology and immunohistochemistry, were performed on an excised specimen of human high thoracic spinal cord, obtained 7 months after the initial trauma, several segments below a severe spinal cord lesion (C5). RESULTS: A precise correlation is described between MRI and immunohistochemistry of the long white matter tracts undergoing Wallerian degeneration and of an extension of the cervical lesion into the high thoracic cord. CONCLUSION: MRI, the only imaging technique that currently provides useful information on the spinal cord parenchyma after trauma, is rapidly evolving. High-field scanners of up to 9.4 T are being clinically tested. The present postmortem investigation of an isolated spinal cord specimen demonstrates the precise correlation that can be achieved between imaging and pathology. In future investigations, this type of technique can lead to a more precise description of spinal cord injuries and their consequences in remote tissue. Translation into the clinical setting will improve diagnosis and follow-up of spinal cord injured patients.
Subject(s)
Cervical Vertebrae/diagnostic imaging , Magnetic Resonance Imaging/methods , Spinal Cord Injuries/diagnostic imaging , Thoracic Vertebrae/diagnostic imaging , Adult , Cervical Vertebrae/chemistry , Cervical Vertebrae/pathology , Humans , Magnetic Resonance Imaging/statistics & numerical data , Male , Radiography , Spinal Cord Injuries/pathology , Thoracic Vertebrae/chemistry , Thoracic Vertebrae/pathology , Time FactorsABSTRACT
BACKGROUND: Interruption of mature axons activates a cascade of events in neuronal cell bodies which leads to various outcomes from functional regeneration in the PNS to the failure of any significant regeneration in the CNS. One factor which seems to play an important role in the molecular programs after axotomy is the stearoyl Coenzyme A-desaturase-1 (SCD-1). This enzyme is needed for the conversion of stearate into oleate. Beside its role in membrane synthesis, oleate could act as a neurotrophic factor, involved in signal transduction pathways via activation of protein kinases C. RESULTS: In situ hybridization and immunohistochemistry demonstrated a strong up-regulation of SCD at mRNA and protein level in regenerating neurons of the rat facial nucleus whereas non-regenerating Clarke's and Red nucleus neurons did not show an induction of this gene. CONCLUSION: This differential expression points to a functionally significant role for the SCD-1 in the process of regeneration.
Subject(s)
Central Nervous System/enzymology , Nerve Regeneration/physiology , Peripheral Nervous System/enzymology , Stearoyl-CoA Desaturase/metabolism , Trauma, Nervous System/enzymology , Animals , Axotomy , Central Nervous System/injuries , Central Nervous System/pathology , Disease Progression , Facial Nerve Injuries/enzymology , Facial Nerve Injuries/pathology , Hypoglossal Nerve/enzymology , Hypoglossal Nerve/pathology , Hypoglossal Nerve Injuries , Immunohistochemistry , In Situ Hybridization , Isoenzymes/metabolism , Neurons/enzymology , Neurons/pathology , Peripheral Nervous System/injuries , Peripheral Nervous System/pathology , Pons/enzymology , Pons/pathology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Red Nucleus/enzymology , Red Nucleus/pathology , Spinal Cord Injuries/enzymology , Spinal Cord Injuries/pathology , Trauma, Nervous System/pathology , Up-RegulationABSTRACT
Vaccinations against various antigens of the central nervous system (CNS) are gaining increasing interest as a therapeutic approach in a variety of neurological diseases such as spinal cord injury, ischemic stroke, Alzheimer disease, or spongiform encephalopathy. In the present work, the time window after spinal cord injury allowing potentially therapeutic antibody to penetrate the damaged blood-brain barrier (BBB) was measured by intravenous injection of a monoclonal anti-Nogo-A antibody. Although an influx of Nogo antibodies at the lesion site was detectable up to 2 wk after injury, a significant decrease in BBB permeability was noticed within the first week. Clearly, therefore, a vaccination protocol with a rapid antibody response is required for acute therapeutic interventions after CNS trauma. We designed a conjugate vaccine paradigm with particular focus on the safety and the kinetics of the antibody response. As antigen targets, we used Nogo-A and the strongly encephalitogenic myelin-oligodendrocyte glycoprotein (MOG). Intrasplenic autoimmunization of rats with a Nogo-A-specific region fused to the Tetanus toxin C-fragment (TTC) resulted in a fast IgM response against Nogo-A. A specific switch to IgG was observed as soon as 4-7 days after intrasplenic immunization in TTC-primed animals. In spite of the induction of a specific IgG response after intrasplenic immunization, no signs of experimental autoimmune disease (EAE) or inflammatory infiltrates on histological examinations were observable. In contrast to subcutaneous immunization with MOG, in vitro cytokine secretion assays (IL-2, IL-10, and IFN-gamma) did not reveal activation of MOG-specific T cells after intrasplenic immunization. Our findings have critical implications for future strategies in the development of safe and efficient therapeutic vaccines for neurological diseases.
Subject(s)
Autoantibodies/biosynthesis , Myelin Proteins/immunology , Myelin-Associated Glycoprotein/immunology , Vaccines/immunology , Vaccines/toxicity , Animals , Antibody Specificity , Antigens/administration & dosage , Autoantibodies/metabolism , Blood-Brain Barrier/metabolism , Encephalitis/diagnosis , Encephalitis/immunology , Kinetics , Lymphocyte Activation , Models, Immunological , Myelin-Oligodendrocyte Glycoprotein , Nervous System Diseases/therapy , Nogo Proteins , Peptide Fragments/administration & dosage , Protein Transport , Rats , Spinal Cord Injuries/immunology , T-Lymphocytes/immunology , Tetanus Toxin/administration & dosageABSTRACT
Nogo-A is a potent neurite growth inhibitor in vitro and plays a role both in the restriction of axonal regeneration after injury and in structural plasticity in the CNS of higher vertebrates. The regions that mediate inhibition and the topology of the molecule in the plasma membrane have to be defined. Here we demonstrate the presence of three different active sites: (1) an N-terminal region involved in the inhibition of fibroblast spreading, (2) a stretch encoded by the Nogo-A-specific exon that restricts neurite outgrowth and cell spreading and induces growth cone collapse, and (3) a C-terminal region (Nogo-66) with growth cone collapsing function. We show that Nogo-A-specific active fragments bind to the cell surface of responsive cells and to rat brain cortical membranes, suggesting the existence of specific binding partners or receptors. Several antibodies against different epitopes on the Nogo-A-specific part of the protein as well as antisera against the 66 aa loop in the C-terminus stain the cell surface of living cultured oligodendrocytes. Nogo-A is also labeled by nonmembrane-permeable biotin derivatives applied to living oligodendrocyte cultures. Immunofluorescent staining of intracellular, endoplasmic reticulum-associated Nogo-A in cells after selective permeabilization of the plasma membrane reveals that the epitopes of Nogo-A, shown to be accessible at the cell surface, are exposed to the cytoplasm. This suggests that Nogo-A could have a second membrane topology. The two proposed topological variants may have different intracellular as well as extracellular functions.
Subject(s)
Myelin Proteins/physiology , Neurites/physiology , 3T3 Cells , Animals , Axons/drug effects , Axons/physiology , Binding Sites/physiology , Biotinylation , Brain Chemistry , CHO Cells , Cell Adhesion , Cell Membrane/chemistry , Cell Membrane/metabolism , Cerebral Cortex/chemistry , Cerebral Cortex/metabolism , Chick Embryo , Cricetinae , Fibroblasts/metabolism , GPI-Linked Proteins , Mice , Molecular Sequence Data , Myelin Proteins/genetics , Myelin Proteins/metabolism , Nogo Proteins , Nogo Receptor 1 , Oligodendroglia/metabolism , Protein Binding/physiology , Protein Isoforms/genetics , Protein Isoforms/physiology , Protein Structure, Tertiary/genetics , Protein Structure, Tertiary/physiology , Rats , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Sequence DeletionABSTRACT
Axotomy of nerve fibers leads to the subsequent degeneration of their distal part, a process termed Wallerian degeneration (WD). While WD in the peripheral nervous system is usually followed by regeneration of the lesioned axons, central nervous system (CNS) neurons are generally unable to regrow. In this study, we investigated the process of WD in the dorsal columns of the rat spinal cord rostral to a mid-thoracic lesion. We confirm earlier studies describing a very delayed microglial and an early and sustained astroglial reaction finally leading to scar formation. Interestingly, we found a differential time course in the loss of myelin proteins depending on their location. Proteins situated on the periaxonal myelin membrane such as myelin associated glycoprotein disappeared early, within a few days after lesion, concomitantly with cytoskeletal axonal proteins, whereas compact myelin and outer myelin membrane proteins such as MBP and Nogo-A remained for long intervals in the degenerating tracts. Two distinct mechanisms are probably responsible for this difference: processes of protein destruction emanating from and initially probably located in the axon act on a time scale of 1-3 days. In contrast, the bulk of myelin destruction is due to phagocytosis known to be slow, prolonged, and inefficient in the CNS. These results may also have implications for future intervention strategies aiming at enhancing CNS regeneration.
Subject(s)
Myelin Proteins/metabolism , Myelin-Associated Glycoprotein/metabolism , Spinal Cord/metabolism , Spinal Cord/pathology , Wallerian Degeneration/metabolism , Wallerian Degeneration/pathology , Animals , Astrocytes/pathology , Cell Survival/physiology , Female , Myelin Basic Protein/metabolism , Nerve Regeneration/physiology , Neurofilament Proteins/metabolism , Nogo Proteins , Rats , Rats, Inbred LewABSTRACT
BACKGROUND: It is well known that neurons of the peripheral nervous system have the capacity to regenerate a severed axon leading to functional recovery, whereas neurons of the central nervous system do not regenerate successfully after injury. The underlying molecular programs initiated by axotomized peripheral and central nervous system neurons are not yet fully understood. RESULTS: To gain insight into the molecular mechanisms underlying the process of regeneration in the nervous system, differential display polymerase chain reaction has been used to identify differentially expressed genes following axotomy of peripheral and central nerve fibers. For this purpose, axotomy induced changes of regenerating facial nucleus neurons, and non-regenerating red nucleus and Clarke's nucleus neurons have been analyzed in an intra-animal side-to-side comparison. One hundred and thirty five gene fragments have been isolated, of which 69 correspond to known genes encoding for a number of different functional classes of proteins such as transcription factors, signaling molecules, homeobox-genes, receptors and proteins involved in metabolism. Sixty gene fragments correspond to genomic mouse sequences without known function. In situ-hybridization has been used to confirm differential expression and to analyze the cellular localization of these gene fragments. Twenty one genes (approximately 15%) have been demonstrated to be differentially expressed. CONCLUSIONS: The detailed analysis of differentially expressed genes in different lesion paradigms provides new insights into the molecular mechanisms underlying the process of regeneration and may lead to the identification of genes which play key roles in functional repair of central nervous tissues.
Subject(s)
Facial Nerve Injuries/genetics , Gene Expression Profiling , Nerve Regeneration/genetics , Neurons/metabolism , Spinal Cord Injuries/genetics , Animals , Axotomy , Brain/metabolism , Brain/pathology , Disease Models, Animal , Facial Nerve Injuries/pathology , Female , Gene Expression Regulation , In Situ Hybridization , Neurons/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Red Nucleus/pathology , Spinal Cord/metabolism , Spinal Cord/pathology , Spinal Cord Injuries/pathology , Stearoyl-CoA Desaturase/genetics , Time FactorsABSTRACT
To investigate the role of the myelin-associated protein Nogo-A on axon sprouting and regeneration in the adult central nervous system (CNS), we generated Nogo-A-deficient mice. Nogo-A knockout (KO) mice were viable, fertile, and not obviously afflicted by major developmental or neurological disturbances. The shorter splice form Nogo-B was strongly upregulated in the CNS. The inhibitory effect of spinal cord extract for growing neurites was decreased in the KO mice. Two weeks following adult dorsal hemisection of the thoracic spinal cord, Nogo-A KO mice displayed more corticospinal tract (CST) fibers growing toward and into the lesion compared to their wild-type littermates. CST fibers caudal to the lesion-regenerating and/or sprouting from spared intact fibers-were also found to be more frequent in Nogo-A-deficient animals.